Literature DB >> 24924665

Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Timothy C Durazzo1, Niklas Mattsson2, Michael W Weiner3.   

Abstract

BACKGROUND: Cigarette smoking has been linked with both increased and decreased risk for Alzheimer's disease (AD). This is relevant for the US military because the prevalence of smoking in the military is approximately 11% higher than in civilians.
METHODS: A systematic review of published studies on the association between smoking and increased risk for AD and preclinical and human literature on the relationships between smoking, nicotine exposure, and AD-related neuropathology was conducted. Original data from comparisons of smoking and never-smoking cognitively normal elders on in vivo amyloid imaging are also presented.
RESULTS: Overall, literature indicates that former/active smoking is related to a significantly increased risk for AD. Cigarette smoke/smoking is associated with AD neuropathology in preclinical models and humans. Smoking-related cerebral oxidative stress is a potential mechanism promoting AD pathology and increased risk for AD.
CONCLUSIONS: A reduction in the incidence of smoking will likely reduce the future prevalence of AD.
Copyright © 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid; Cigarette smoking; Military; Oxidative stress; Risk; Tau; Tobacco; U.S. Armed Services

Mesh:

Substances:

Year:  2014        PMID: 24924665      PMCID: PMC4098701          DOI: 10.1016/j.jalz.2014.04.009

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  250 in total

1.  Differences between smokers and nonsmokers in regional gray matter volumes and densities.

Authors:  Arthur L Brody; Mark A Mandelkern; Murray E Jarvik; Grace S Lee; Erlyn C Smith; Joe C Huang; Robert G Bota; George Bartzokis; Edythe D London
Journal:  Biol Psychiatry       Date:  2004-01-01       Impact factor: 13.382

2.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

3.  Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.

Authors:  Kaarin J Anstey; Chwee von Sanden; Agus Salim; Richard O'Kearney
Journal:  Am J Epidemiol       Date:  2007-06-14       Impact factor: 4.897

4.  Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.

Authors:  Susan M Landau; Christopher Breault; Abhinay D Joshi; Michael Pontecorvo; Chester A Mathis; William J Jagust; Mark A Mintun
Journal:  J Nucl Med       Date:  2012-11-19       Impact factor: 10.057

5.  MRI identification of early white matter injury in anoxic-ischemic encephalopathy.

Authors:  J A Chalela; R L Wolf; J A Maldjian; S E Kasner
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

6.  Smoking affects the phenotype of Alzheimer disease.

Authors:  M N Sabbagh; S L Tyas; S C Emery; L A Hansen; M F Alford; R T Reid; P Tiraboschi; L J Thal
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

Review 7.  Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging.

Authors:  J E Slemmer; J J Shacka; M I Sweeney; J T Weber
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  An 18-month follow-up study on the influence of smoking on blood antioxidant status of teenage girls in comparison with adult male smokers in Korea.

Authors:  Sun H Kim; Jodi L Ensunsa; Qin Yan Zhu; Jung S Kim; Ho S Shin; Carl L Keen
Journal:  Nutrition       Date:  2004-05       Impact factor: 4.008

9.  Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat.

Authors:  Tadanobu Utsuki; Mohammed Shoaib; Harold W Holloway; Donald K Ingram; William C Wallace; Vahram Haroutunian; Kumar Sambamurti; Debomoy K Lahiri; Nigel H Greig
Journal:  J Alzheimers Dis       Date:  2002-10       Impact factor: 4.472

10.  Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Authors:  L J Launer; K Andersen; M E Dewey; L Letenneur; A Ott; L A Amaducci; C Brayne; J R Copeland; J F Dartigues; P Kragh-Sorensen; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

View more
  118 in total

1.  Differential Sphingolipid and Phospholipid Profiles in Alcohol and Nicotine-Derived Nitrosamine Ketone-Associated White Matter Degeneration.

Authors:  Emine B Yalcin; Kavin Nunez; Ming Tong; Suzanne M de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2015-12       Impact factor: 3.455

Review 2.  Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.

Authors:  Haijun Han; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-13       Impact factor: 4.147

3.  An International Evaluation of Cognitive Reserve and Memory Changes in Early Old Age in 10 European Countries.

Authors:  Dorina Cadar; Annie Robitaille; Sean Clouston; Scott M Hofer; Andrea M Piccinin; Graciela Muniz-Terrera
Journal:  Neuroepidemiology       Date:  2017-02-21       Impact factor: 3.282

Review 4.  A critical review of assays for hazardous components of air pollution.

Authors:  Henry Jay Forman; Caleb Ellicott Finch
Journal:  Free Radic Biol Med       Date:  2018-01-31       Impact factor: 7.376

Review 5.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen'.

Authors:  Erik S Musiek; David M Holtzman
Journal:  Nat Neurosci       Date:  2015-06       Impact factor: 24.884

6.  Effects of cigarette smoking history on neurocognitive recovery over 8 months of abstinence in alcohol-dependent individuals.

Authors:  Timothy C Durazzo; David L Pennington; Thomas P Schmidt; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2014-10-21       Impact factor: 3.455

7.  Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Nicotine Tob Res       Date:  2015-04-06       Impact factor: 4.244

Review 8.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

9.  Perceptions of Risk Factors for Alzheimer Disease Among Community-Dwelling, Nondemented Older African Americans.

Authors:  Crystal M Glover; Shelytia CoCroft; Bryan D James; Lisa L Barnes
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jul-Sep       Impact factor: 2.703

10.  What is Your Risk of Contracting Alzheimer's Disease? A Telematics Tool Helps you to Predict it.

Authors:  Rodrigo Méndez-Sanz; Isabel de la Torre-Díez; Miguel López-Coronado
Journal:  J Med Syst       Date:  2015-10-29       Impact factor: 4.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.